Beijing Wantai Biological Pharmacy Enterprise Co Ltd Tangible Net Worth Ratio
Beijing Wantai Biological Pharmacy Enterprise Co Ltd tangible net worth ratio. Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a Tangible Net Worth Ratio of 91.6% as of June 2026. This metric is calculated by deducting intangible assets (CN¥1.00 Billion) from net assets (CN¥11.90 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 603392 net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)
Tangible net worth ratio of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025. This chart shows how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 91.6%, reflecting net assets of CN¥11.90 Billion with intangible assets of CN¥1.00 Billion CNY. Check Beijing Wantai Biological Pharmacy Enter PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Tangible Net Worth Ratio by Year (2013–2025)
Beijing Wantai Biological Pharmacy Enterprise Co Ltd tangible net worth ratio by year from 2013 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see how much is Beijing Wantai Biological Pharmacy Enter worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | CN¥12.03 Billion | CN¥962.96 Million | CN¥14.04 Billion | ▼ -2.3 pp |
| 2024 | 94.3% | CN¥12.45 Billion | CN¥712.86 Million | CN¥14.69 Billion | ▼ -0.7 pp |
| 2023 | 95.0% | CN¥12.88 Billion | CN¥642.74 Million | CN¥15.71 Billion | ▼ -2.3 pp |
| 2022 | 97.4% | CN¥12.56 Billion | CN¥332.38 Million | CN¥16.23 Billion | ▲ +3.8 pp |
| 2021 | 93.5% | CN¥4.56 Billion | CN¥295.13 Million | CN¥7.05 Billion | ▲ +2.6 pp |
| 2020 | 90.9% | CN¥2.58 Billion | CN¥233.95 Million | CN¥3.50 Billion | ▲ +6.2 pp |
| 2019 | 84.7% | CN¥1.58 Billion | CN¥242.03 Million | CN¥2.16 Billion | ▲ +2.8 pp |
| 2018 | 81.8% | CN¥1.37 Billion | CN¥248.87 Million | CN¥1.81 Billion | ▲ +10.1 pp |
| 2017 | 71.8% | CN¥898.99 Million | CN¥253.90 Million | CN¥1.66 Billion | ▼ -0.8 pp |
| 2016 | 72.6% | CN¥959.70 Million | CN¥263.05 Million | CN¥1.45 Billion | ▼ -0.6 pp |
| 2015 | 73.2% | CN¥722.69 Million | CN¥193.40 Million | CN¥1.10 Billion | ▼ -17.3 pp |
| 2014 | 90.5% | CN¥580.32 Million | CN¥55.08 Million | CN¥805.50 Million | ▲ +5.2 pp |
| 2013 | 85.3% | CN¥382.06 Million | CN¥56.31 Million | CN¥606.98 Million | — |